Redhill Biopharma Ltd. sell Ruckelsbuckel
Start price
29.11.23
/
0%
€2.71
Target price
29.11.24
€0.30
Performance (%)
-81.33%
End price
19.02.24
€0.51
Summary
This prediction ended on 19.02.24 with a price of €0.51. Ruckelsbuckel correctly predicted massive losses of -81.33% for Redhill Biopharma Ltd.. This prediction was marked as speculative and is excluded from Ruckelsbuckel's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Redhill Biopharma Ltd. | -1.063% | -1.063% |
| iShares Core DAX® | -0.552% | 3.405% |
| iShares Nasdaq 100 | -1.415% | 4.613% |
| iShares Nikkei 225® | -0.877% | -1.396% |
| iShares S&P 500 | -0.415% | 3.338% |
According to Ruckelsbuckel what are the pros and cons of Redhill Biopharma Ltd. for the foreseeable future?
Pros
Capable Management
Very good company culture
Innovative
Sustainability is important
Stable Large shareholder and/or long term investor
Cons
Bad rating
Below average Marketposition
EBIT decline/stagnation expected
Few uniques
Risky Investment
Revenue decline/stagnation expected
Decining EBIT margin than peer group
High valuation
Very low/no dividend yield expected
negative Cash Flow expected
High risks in the balance sheet
ROE lower than 5% per year
Very little Investments for future growth
High challenges to pay loans and raise capital
Dependend from some customers or products
Growths slower than the competition
High risks for its business
Very high cyclical dependencies
Little known brand
Business model of the past or high risk
Comments by Ruckelsbuckel for this prediction
In the thread Redhill Biopharma Ltd. diskutieren
Sell mit Kursziel 0,0
Kursziel geändert auf 0,3